{"id":"https://openalex.org/W4401047672","doi":"https://doi.org/10.7759/cureus.65521","title":"The Effect of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists on the Lipid Profile of Diabetic Patients Using Statins: A Retrospective Cohort Study in the Diabetic Center of King Salman Bin Abdulaziz Hospital, Saudi Arabia","display_name":"The Effect of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists on the Lipid Profile of Diabetic Patients Using Statins: A Retrospective Cohort Study in the Diabetic Center of King Salman Bin Abdulaziz Hospital, Saudi Arabia","publication_year":2024,"publication_date":"2024-07-27","ids":{"openalex":"https://openalex.org/W4401047672","doi":"https://doi.org/10.7759/cureus.65521","pmid":"https://pubmed.ncbi.nlm.nih.gov/39188504","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11346815"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.65521","doi":"https://doi.org/10.7759/cureus.65521","is_oa":true,"landing_page_url":"http://dx.doi.org/10.7759/cureus.65521","pdf_url":"https://www.cureus.com/articles/279066-the-effect-of-glucagon-like-peptide-1-glp-1-receptor-agonists-on-the-lipid-profile-of-diabetic-patients-using-statins-a-retrospective-cohort-study-in-the-diabetic-center-of-king-salman-bin-abdulaziz-hospital-saudi-arabia.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/279066-the-effect-of-glucagon-like-peptide-1-glp-1-receptor-agonists-on-the-lipid-profile-of-diabetic-patients-using-statins-a-retrospective-cohort-study-in-the-diabetic-center-of-king-salman-bin-abdulaziz-hospital-saudi-arabia.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113097999","display_name":"Odai M Albahli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127754","display_name":"Ministry of Health","ror":"https://ror.org/030atj633","country_code":"SA","type":"government","lineage":["https://openalex.org/I4210127754"]}],"countries":["SA"],"is_corresponding":true,"raw_author_name":"Odai M Albahli","raw_affiliation_strings":["Family Medicine, Kingdom of Saudi Arabia Ministry of Health, Riyadh, SAU",". Endocrinology and Diabetes, King Salman Hospital, Riyadh, SAU"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Family Medicine, Kingdom of Saudi Arabia Ministry of Health, Riyadh, SAU","institution_ids":["https://openalex.org/I4210127754"]},{"raw_affiliation_string":". Endocrinology and Diabetes, King Salman Hospital, Riyadh, SAU","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115599787","display_name":"Saqib Ali","orcid":"https://orcid.org/0000-0002-1925-2350","observed_orcids":["https://orcid.org/0000-0002-1925-2350","https://orcid.org/0000-0002-6338-4385"]},"institutions":[{"id":"https://openalex.org/I4210127754","display_name":"Ministry of Health","ror":"https://ror.org/030atj633","country_code":"SA","type":"government","lineage":["https://openalex.org/I4210127754"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Saqib Ali","raw_affiliation_strings":["Endocrinology and Diabetes, King Salman Hospital, Riyadh, SAU",". Family Medicine, Kingdom of Saudi Arabia Ministry of Health, Riyadh, SAU"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrinology and Diabetes, King Salman Hospital, Riyadh, SAU","institution_ids":[]},{"raw_affiliation_string":". Family Medicine, Kingdom of Saudi Arabia Ministry of Health, Riyadh, SAU","institution_ids":["https://openalex.org/I4210127754"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058074930","display_name":"Fahad Alblaihi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127754","display_name":"Ministry of Health","ror":"https://ror.org/030atj633","country_code":"SA","type":"government","lineage":["https://openalex.org/I4210127754"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Fahad Alblaihi","raw_affiliation_strings":["Endocrinology and Diabetes, King Salman Hospital, Riyadh, SAU",". Family Medicine, Kingdom of Saudi Arabia Ministry of Health, Riyadh, SAU"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrinology and Diabetes, King Salman Hospital, Riyadh, SAU","institution_ids":[]},{"raw_affiliation_string":". Family Medicine, Kingdom of Saudi Arabia Ministry of Health, Riyadh, SAU","institution_ids":["https://openalex.org/I4210127754"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000313132","display_name":"Abdulaziz Aljamaan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127754","display_name":"Ministry of Health","ror":"https://ror.org/030atj633","country_code":"SA","type":"government","lineage":["https://openalex.org/I4210127754"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Abdulaziz A Aljaman","raw_affiliation_strings":["Endocrinology and Diabetes, King Salman Hospital, Riyadh, SAU",". Family Medicine, Kingdom of Saudi Arabia Ministry of Health, Riyadh, SAU"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrinology and Diabetes, King Salman Hospital, Riyadh, SAU","institution_ids":[]},{"raw_affiliation_string":". Family Medicine, Kingdom of Saudi Arabia Ministry of Health, Riyadh, SAU","institution_ids":["https://openalex.org/I4210127754"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5113097999"],"corresponding_institution_ids":["https://openalex.org/I4210127754"],"apc_list":null,"apc_paid":null,"fwci":1.0474,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.74777214,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":96},"biblio":{"volume":"16","issue":"7","first_page":"e65521","last_page":"e65521"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9900000095367432},{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9399999976158142},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.9350000023841858},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.75},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":1.0},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7829999923706055},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9399999976158142},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.6309999823570251},{"id":"https://openalex.org/keywords/saudi-arabia","display_name":"Saudi Arabia","score":0.38600000739097595},{"id":"https://openalex.org/keywords/diabetes-comorbidity","display_name":"diabetes comorbidity","score":0.6029999852180481},{"id":"https://openalex.org/keywords/retinopathy","display_name":"retinopathy","score":0.6980000138282776},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.8889999985694885},{"id":"https://openalex.org/keywords/mean-corpuscular-volume","display_name":"mean corpuscular volume","score":0.8479999899864197},{"id":"https://openalex.org/keywords/hemoglobin","display_name":"hemoglobin","score":0.5509999990463257}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9303925037384033},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.8539130687713623},{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.8357856273651123},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.6150395274162292},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5530234575271606},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5467802286148071},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.49144089221954346},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.45761388540267944},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.453194260597229},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.44900307059288025},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.4399254620075226},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4319274425506592},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3702574372291565},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.13635772466659546},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.7759/cureus.65521","doi":"https://doi.org/10.7759/cureus.65521","is_oa":true,"landing_page_url":"http://dx.doi.org/10.7759/cureus.65521","pdf_url":"https://www.cureus.com/articles/279066-the-effect-of-glucagon-like-peptide-1-glp-1-receptor-agonists-on-the-lipid-profile-of-diabetic-patients-using-statins-a-retrospective-cohort-study-in-the-diabetic-center-of-king-salman-bin-abdulaziz-hospital-saudi-arabia.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11346815","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11346815","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11346815/pdf/cureus-0016-00000065521.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Text"},{"id":"pmid:39188504","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39188504","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7759/cureus.65521","doi":"https://doi.org/10.7759/cureus.65521","is_oa":true,"landing_page_url":"http://dx.doi.org/10.7759/cureus.65521","pdf_url":"https://www.cureus.com/articles/279066-the-effect-of-glucagon-like-peptide-1-glp-1-receptor-agonists-on-the-lipid-profile-of-diabetic-patients-using-statins-a-retrospective-cohort-study-in-the-diabetic-center-of-king-salman-bin-abdulaziz-hospital-saudi-arabia.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4401047672.pdf","grobid_xml":"https://content.openalex.org/works/W4401047672.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1518639300","https://openalex.org/W2062883844","https://openalex.org/W2130777905","https://openalex.org/W2130813021","https://openalex.org/W2494378790","https://openalex.org/W2770060528","https://openalex.org/W2979241049","https://openalex.org/W3081805368","https://openalex.org/W3096890405","https://openalex.org/W3108676144","https://openalex.org/W3112461052","https://openalex.org/W3164564280","https://openalex.org/W3203692738","https://openalex.org/W3203975425","https://openalex.org/W4238250012","https://openalex.org/W4313025916","https://openalex.org/W4324357641","https://openalex.org/W4386998464","https://openalex.org/W4387500304","https://openalex.org/W4387969792"],"related_works":["https://openalex.org/W4324357641","https://openalex.org/W2770060528","https://openalex.org/W2072750268","https://openalex.org/W4399327139","https://openalex.org/W2869651365","https://openalex.org/W4324334120","https://openalex.org/W4377043434","https://openalex.org/W2163892210","https://openalex.org/W4412523850","https://openalex.org/W3035160751"],"abstract_inverted_index":{"Background":[0],"Dyslipidemia":[1],"is":[2,13],"a":[3,223,255],"common":[4],"complication":[5],"of":[6,17,69,81,87,105,123,157,229,236,276,288,296],"type":[7],"2":[8],"diabetes":[9],"mellitus":[10],"(T2DM),":[11],"which":[12],"the":[14,50,70,79,84,102,120,147,161,165,237,247,285,289,293],"leading":[15],"cause":[16],"morbidity":[18],"and":[19,60,63,107,133,151,160,171,180,194,209,243,270],"mortality":[20],"in":[21,40,43,129,149,167,258],"developed":[22],"countries,":[23],"including":[24],"Saudi":[25,131],"Arabia.":[26],"Injectable":[27],"glucagon-like":[28],"peptide-1":[29],"receptor":[30],"agonists":[31],"(GLP-1RA)":[32],"are":[33],"recent":[34],"therapies":[35],"found":[36],"to":[37,49,77,119,140,177,189],"be":[38],"effective":[39],"treating":[41],"dyslipidemia":[42,88,112,300],"diabetic":[44,89,109,121,297],"patients":[45,90,110,221,298],"by":[46,114,204,302],"acting":[47],"similarly":[48],"body's":[51],"internal":[52],"glucagon":[53],"peptide":[54],"hormone,":[55],"regulating":[56],"blood":[57],"sugar":[58],"levels":[59,153],"reducing":[61],"triglycerides":[62,150],"low-density":[64],"lipoprotein":[65],"(LDL)":[66],"levels.":[67],"Aim":[68],"study":[71,75,218,253,282],"This":[72],"retrospective":[73],"cohort":[74],"aimed":[76],"investigate":[78],"effect":[80,287],"GLP-1RA":[82,135,290],"on":[83,292],"lipid":[85,294],"profile":[86,295],"who":[91,116],"were":[92,99,117,200,246],"not":[93],"controlled":[94],"using":[95,158,196,277],"statins.":[96,303],"Methods":[97],"Data":[98],"collected":[100],"from":[101,137],"medical":[103],"records":[104],"male":[106],"female":[108],"with":[111,222,299],"(uncontrolled":[113],"statins)":[115],"administered":[118],"center":[122],"King":[124],"Salman":[125],"Bin":[126],"Abdulaziz":[127],"Hospital":[128],"Riyadh,":[130],"Arabia,":[132],"received":[134],"(dulaglutide)":[136,291],"June":[138],"2023":[139],"August":[141],"2023.":[142],"The":[143,183,217,252],"primary":[144],"endpoint":[145],"was":[146,175,187],"change":[148,166],"LDL-C":[152],"after":[154,195,273],"three":[155,274],"months":[156,275],"dulaglutide,":[159],"secondary":[162],"endpoints":[163],"included":[164,219],"body":[168,259],"weight,":[169,260],"BMI,":[170,261],"HbA1c%.":[172],"Descriptive":[173],"analysis":[174],"conducted":[176],"present":[178],"numerical":[179,191],"categorical":[181],"data.":[182],"Wilcoxon":[184],"signed-rank":[185],"test":[186],"used":[188],"compare":[190],"data":[192,207,214],"before":[193,213],"dulaglutide.":[197],"Ethical":[198],"considerations":[199],"taken":[201],"into":[202],"account":[203],"ensuring":[205],"anonymous":[206],"collection":[208],"obtaining":[210],"IRB":[211],"approval":[212],"collection.":[215],"Results":[216],"102":[220],"median":[224],"(interquartile":[225],"range":[226],"(IQR))":[227],"age":[228],"59":[230],"(14)":[231],"years.":[232],"Females":[233],"constituted":[234],"55.2%":[235],"population.":[238],"Obesity":[239],"(96.1%),":[240],"hypertension":[241],"(71.6%),":[242],"retinopathy":[244],"(13.7%)":[245],"most":[248],"commonly":[249],"reported":[250],"comorbidities.":[251],"showed":[254],"significant":[256],"reduction":[257],"HbA1c,":[262],"hemoglobin,":[263],"mean":[264],"corpuscular":[265],"volume":[266],"(MCV),":[267],"serum":[268],"LDL-C,":[269],"triglyceride":[271],"concentrations":[272],"dulaglutide":[278],"(p<0.001).":[279],"Conclusion":[280],"Our":[281],"results":[283],"confirm":[284],"positive":[286],"uncontrolled":[301]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2024-07-31T00:00:00"}